Intratumoral heterogeneity of intrahepatic cholangiocarcinoma

No personalized therapy regimens could demonstrate a benefit in survival of intrahepatic cholangiocarcinoma (iCCA). Since genetic heterogeneity might influence single biopsy based targeted therapy or the outcome of clinical trials, aim of the present study was to investigate intratumoral heterogenei...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Dirk, Döring, Claudia, Feldhahn, Magdalena, Battke, Florian, Hartmann, Sylvia, Winkelmann, Ria, Schneider, Markus, Bankov, Katrin, Schnitzbauer, Andreas, Zeuzem, Stefan, Hansmann, Martin Leo, Peveling-Oberhag, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362457/
https://www.ncbi.nlm.nih.gov/pubmed/28146430
http://dx.doi.org/10.18632/oncotarget.14844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362457/
https://www.ncbi.nlm.nih.gov/pubmed/28146430
http://dx.doi.org/10.18632/oncotarget.14844

Ejemplares similares